Focus on Wuhan | Huapont Shengchem to Exhibit at API China, Booth B2G03 Connecting Global Business

From November 11 to 13, 2026, the 95th APi China (International Exhibition for Pharmaceutical Ingredients, Intermediates, Packaging, and Equipment) will be held at the Wuhan International Expo Center. As a core city of the Yangtze River Economic Belt and a pharmaceutical hub in Central China, Wuhan will welcome over 2,000 exhibitors and 120,000 professional visitors across an exhibition area of 80,000 square meters, creating a premier platform linking China’s pharmaceutical industry with global markets.

Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. is pleased to announce its participation at Booth B2G03, and cordially invites partners from around the world to visit us and explore new opportunities for cooperation. Huapont Shengchem specializes in the R&D, manufacturing, CDMO, sales, and export of APIs. The company operates two modern API manufacturing sites and one R&D center in Chongqing. Its product portfolio covers more than 20 therapeutic areas, including retinoids, vitamin D3 derivatives, and oncology products. The company has obtained registrations in over 60 countries, including China, the United States, the European Union, and Japan.

At this event, Huapont Shengchem will highlight its differentiated API portfolio and one-stop CDMO capabilities, covering the full chain from intermediates to APIs and from gram-scale to ton-scale production. We look forward to meeting global partners in Wuhan to discuss industry trends and explore collaborative opportunities.

We warmly welcome you to visit us at Booth B2G03 at the Wuhan International Expo Center. 

Schedule a meeting, please contact:

Email: api@huapont.cn

Website: https://www.huapontshengchem.com/

You are welcome to visit our official website or send us an email. Our business team will arrange a dedicated meeting for you as soon as possible.